EirGenix (Taiwan) Insiders
| 6589 Stock | TWD 80.50 4.00 5.23% |
EirGenix employs about 20 people. The company is managed by 6 executives with a total tenure of roughly 12 years, averaging almost 2.0 years of service per executive, having 3.33 employees per reported executive. Recap of EirGenix's management performance can provide insight into the venture performance.
| ChihJung Chang COO Chief Operating Officer, Chief Manufacturing Officer, Deputy General Manager |
| AeNing Lin Executive Ex Control |
EirGenix |
EirGenix Management Team Effectiveness
The company has return on total asset (ROA) of (0.0168) % which means that it has lost $0.0168 on every $100 spent on assets. This is way below average. EirGenix's management efficiency ratios could be used to measure how well EirGenix manages its routine affairs as well as how well it operates its assets and liabilities.EirGenix Workforce Comparison
EirGenix is rated below average in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 1,253. EirGenix claims roughly 20.0 in number of employees contributing just under 2% to stocks in Biotechnology industry.
EirGenix Notable Stakeholders
An EirGenix stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as EirGenix often face trade-offs trying to please all of them. EirGenix's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting EirGenix's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| HsiuChuan Yang | Head CFO | Profile | |
| ChihJung Chang | Chief Operating Officer, Chief Manufacturing Officer, Deputy General Manager | Profile | |
| LeeCheng Liu | General Manager, Chief of Research & Development Officer, Director | Profile | |
| AeNing Lin | Ex Control | Profile | |
| ShangChung Ju | Ex Officer | Profile | |
| Thomas Schulze | Deputy General Manager | Profile |
About EirGenix Management Performance
The success or failure of an entity such as EirGenix often depends on how effective the management is. EirGenix management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of EirGenix management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the EirGenix management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
EirGenix Inc. operates as a contract development and manufacturing company worldwide. Its services include cell line development, process development, analytical sciences and quality control, cGMP manufacturing, and antibody drug conjugate. EIRGENIX INC operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. It employs 179 people.
Please note, the imprecision that can be found in EirGenix's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of EirGenix. Check EirGenix's Beneish M Score to see the likelihood of EirGenix's management manipulating its earnings.
EirGenix Workforce Analysis
Traditionally, organizations such as EirGenix use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare EirGenix within its industry.EirGenix Manpower Efficiency
Return on EirGenix Manpower
| Revenue Per Employee | 84.9M | |
| Revenue Per Executive | 282.9M | |
| Net Loss Per Employee | 2.1M | |
| Net Loss Per Executive | 7.1M |
Additional Tools for EirGenix Stock Analysis
When running EirGenix's price analysis, check to measure EirGenix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EirGenix is operating at the current time. Most of EirGenix's value examination focuses on studying past and present price action to predict the probability of EirGenix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EirGenix's price. Additionally, you may evaluate how the addition of EirGenix to your portfolios can decrease your overall portfolio volatility.